Updated annexes to the eSubmission roadmap published

The following updated Annexes to the eSubmission Roadmap have been published to reflect further details on the practical implementation steps. Annex 3 to the HMA eSubmission Roadmap on the implementation of mandatory VNeeS format for Veterinary regulatory submissions, Annex 4 to the HMA eSubmission Roadmap on the replacement of the current PDF electronic application forms [...]

Por |2023-08-17T02:48:01+00:00agosto 17th, 2023|Noticias|Sin comentarios

updated Annexes to the Roadmap

The updated Annexes to the Roadmap are being published as they become available to reflect further details on the practical implementation steps. Annex 1 to the HMA eSubmission Roadmap on the implementation of eCTD version 4.0 and Annex 2 to the HMA eSubmission Roadmap on the implementation of mandatory use of eCTD format for Human [...]

Por |2023-08-16T02:36:26+00:00agosto 16th, 2023|Noticias|Sin comentarios

Common Repository (User Interface and API) is now extended to include the following types of submissions related to procedures for Human Medicinal Products: Signal Detection, PASS 107 NAPs, Work share NAPs and Ancillary products for new submissions from the 8th of March 2018 onwards.

Common Repository (User Interface and API) is now extended to include the following types of submissions related to procedures for Human Medicinal Products: Signal Detection, PASS 107 NAPs, Work share NAPs and Ancillary products for new submissions from the 8th of March 2018 onwards. This will be followed by a transitional period of 6-9 months, [...]

Por |2023-08-11T02:17:33+00:00agosto 11th, 2023|Noticias|Sin comentarios

The CHMP Pharmacovigilance Working…

The CHMP Pharmacovigilance Working Party (PhVWP) was responsible for evaluating and monitoring safety issues for human medicines until 2012; it was then replaced by the Pharmacovigilance Risk Assessment Committee (PRAC) with the entry into force of Directive 2010/84/EU. PhVWP recommendation

Por |2023-08-04T14:05:02+00:00agosto 4th, 2023|Noticias|Sin comentarios
Ir a Arriba